Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.02
OTCPK:SNWV's Cash-to-Debt is ranked lower than
93% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. OTCPK:SNWV: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
OTCPK:SNWV' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 7.78 Max: No Debt
Current: 0.02
Equity-to-Asset -6.88
OTCPK:SNWV's Equity-to-Asset is ranked lower than
98% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. OTCPK:SNWV: -6.88 )
Ranked among companies with meaningful Equity-to-Asset only.
OTCPK:SNWV' s Equity-to-Asset Range Over the Past 10 Years
Min: -6.88  Med: -3.47 Max: -0.25
Current: -6.88
-6.88
-0.25
Piotroski F-Score: 3
Altman Z-Score: -162.48
Beneish M-Score: -3.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -240.99
OTCPK:SNWV's Operating Margin % is ranked lower than
88% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. OTCPK:SNWV: -240.99 )
Ranked among companies with meaningful Operating Margin % only.
OTCPK:SNWV' s Operating Margin % Range Over the Past 10 Years
Min: -1621.98  Med: -788.3 Max: -240.99
Current: -240.99
-1621.98
-240.99
Net Margin % -468.02
OTCPK:SNWV's Net Margin % is ranked lower than
89% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. OTCPK:SNWV: -468.02 )
Ranked among companies with meaningful Net Margin % only.
OTCPK:SNWV' s Net Margin % Range Over the Past 10 Years
Min: -2049.73  Med: -899.52 Max: -467.95
Current: -468.02
-2049.73
-467.95
ROA % -629.52
OTCPK:SNWV's ROA % is ranked lower than
98% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. OTCPK:SNWV: -629.52 )
Ranked among companies with meaningful ROA % only.
OTCPK:SNWV' s ROA % Range Over the Past 10 Years
Min: -657.17  Med: -214.21 Max: -99.51
Current: -629.52
-657.17
-99.51
ROC (Joel Greenblatt) % -17270.83
OTCPK:SNWV's ROC (Joel Greenblatt) % is ranked lower than
99% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. OTCPK:SNWV: -17270.83 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
OTCPK:SNWV' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -73966.67  Med: -23152.94 Max: -4578.32
Current: -17270.83
-73966.67
-4578.32
3-Year Revenue Growth Rate -22.60
OTCPK:SNWV's 3-Year Revenue Growth Rate is ranked lower than
86% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. OTCPK:SNWV: -22.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
OTCPK:SNWV' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -24.2 Max: -13.9
Current: -22.6
3-Year EBITDA Growth Rate -55.70
OTCPK:SNWV's 3-Year EBITDA Growth Rate is ranked lower than
92% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. OTCPK:SNWV: -55.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
OTCPK:SNWV' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -55.7  Med: -26.9 Max: 838.3
Current: -55.7
-55.7
838.3
3-Year EPS without NRI Growth Rate -47.70
OTCPK:SNWV's 3-Year EPS without NRI Growth Rate is ranked lower than
84% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. OTCPK:SNWV: -47.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
OTCPK:SNWV' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -37.15 Max: -20.4
Current: -47.7
GuruFocus has detected 5 Warning Signs with SANUWAVE Health Inc $OTCPK:SNWV.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» OTCPK:SNWV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with SNWV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 325414    SIC: 2836
Compare:NAS:EVAR, OTCPK:VASO, OTCPK:MRIC, NAS:AMDA, OTCPK:GCHIF, OTCPK:IMPZY, OTCPK:ARCRF, OTCPK:FGCN, OTCPK:SMLR, OTCPK:NIMU, OTCPK:CRVW, OTCPK:MRLB, AMEX:MICR, AMEX:XTNT, OTCPK:RMSL, NAS:LLIT, OTCPK:PBIO, OTCPK:ZYXI, NAS:DYNT, OTCPK:PYNGF » details
Headquarter Location:USA
SANUWAVE Health Inc is a shockwave technology company. It uses a patented system of shockwaves for regenerative medicine and other applications. Its product includes dermaPACE device which is used for treating diabetic foot ulcers.

SANUWAVE Health Inc formerly known as Rub Music Enterprises, Inc., was incorporated in the State of Nevada on May 6, 2004. The Company is a shockwave technology company using a patented system of noninvasive, high-energy, acoustic shockwaves for regenerative medicine and other applications. Its regenerative product in the United States is the demaPACE device, used for treating diabetic foot ulcers subject to submission of satisfactory clinical study results. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The Company faces competition from medical device, biomedical technology and medical products and combination products companies, including major pharmaceutical companies. The Company's product candidates are subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act and/or the Public Health Service Act, as well as by other regulatory bodies.

Ratios

vs
industry
vs
history
PS Ratio 7.14
SNWV's PS Ratio is ranked lower than
83% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SNWV: 7.14 )
Ranked among companies with meaningful PS Ratio only.
SNWV' s PS Ratio Range Over the Past 10 Years
Min: 2.5  Med: 12.18 Max: 100
Current: 7.14
2.5
100
EV-to-EBIT -6.16
SNWV's EV-to-EBIT is ranked lower than
99.99% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. SNWV: -6.16 )
Ranked among companies with meaningful EV-to-EBIT only.
SNWV' s EV-to-EBIT Range Over the Past 10 Years
Min: -8.1  Med: -2.7 Max: -0.1
Current: -6.16
-8.1
-0.1
EV-to-EBITDA -6.83
SNWV's EV-to-EBITDA is ranked lower than
99.99% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. SNWV: -6.83 )
Ranked among companies with meaningful EV-to-EBITDA only.
SNWV' s EV-to-EBITDA Range Over the Past 10 Years
Min: -8.9  Med: -2.9 Max: -0.1
Current: -6.83
-8.9
-0.1
Current Ratio 0.12
SNWV's Current Ratio is ranked lower than
92% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. SNWV: 0.12 )
Ranked among companies with meaningful Current Ratio only.
SNWV' s Current Ratio Range Over the Past 10 Years
Min: 0.1  Med: 0.35 Max: 1.97
Current: 0.12
0.1
1.97
Quick Ratio 0.09
SNWV's Quick Ratio is ranked lower than
91% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. SNWV: 0.09 )
Ranked among companies with meaningful Quick Ratio only.
SNWV' s Quick Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.21 Max: 1.8
Current: 0.09
0.08
1.8
Days Inventory 164.48
SNWV's Days Inventory is ranked lower than
81% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. SNWV: 164.48 )
Ranked among companies with meaningful Days Inventory only.
SNWV' s Days Inventory Range Over the Past 10 Years
Min: 164.48  Med: 517.72 Max: 1032.01
Current: 164.48
164.48
1032.01
Days Sales Outstanding 122.29
SNWV's Days Sales Outstanding is ranked higher than
81% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. SNWV: 122.29 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNWV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.15  Med: 37.27 Max: 122.29
Current: 122.29
18.15
122.29
Days Payable 460.61
SNWV's Days Payable is ranked higher than
97% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. SNWV: 460.61 )
Ranked among companies with meaningful Days Payable only.
SNWV' s Days Payable Range Over the Past 10 Years
Min: 384.91  Med: 1009.18 Max: 2671.8
Current: 460.61
384.91
2671.8

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -53.40
SNWV's 3-Year Average Share Buyback Ratio is ranked lower than
89% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. SNWV: -53.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SNWV' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -53.4  Med: -27.9 Max: 28.6
Current: -53.4
-53.4
28.6

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.71
SNWV's Price-to-Median-PS-Value is ranked higher than
78% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. SNWV: 0.71 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SNWV' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36  Med: 0.91 Max: 6.1
Current: 0.71
0.36
6.1
Earnings Yield (Greenblatt) % -16.22
SNWV's Earnings Yield (Greenblatt) % is ranked lower than
84% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. SNWV: -16.22 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SNWV' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -286.54  Med: 0 Max: 0
Current: -16.22
-286.54
0

More Statistics

Revenue (TTM) (Mil) $1.38
EPS (TTM) $ -0.07
Beta-1.65
Short Percentage of Float0.00%
52-Week Range $0.03 - 0.20
Shares Outstanding (Mil)137.10
» More Articles for SNWV

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
SNWV: Record Revenue As International Strategy Builds Momentum Apr 07 2017
Edited Transcript of SNWV earnings conference call or presentation 4-Apr-17 2:00pm GMT Apr 04 2017
Sanuwave Health Reports Record Revenue in 2016 and Provides a Business Update Apr 04 2017
SANUWAVE Health to Hold 2016 Financial Results and Business Update Call on Tuesday, April 4, 2017 Mar 31 2017
SANUWAVE Health, Inc. Announces Latest "SHOCK THIS" Blog Mar 30 2017
SANUWAVE Receives U.S. Patent for a Special Construction of Shock Wave Electrodes and the Method to... Feb 24 2017
SANUWAVE Health, Inc. Launches "SHOCK THIS" Blog Feb 23 2017
SANUWAVE Announces Hiring of Andre Mouton as VP of International Sales and Relations Feb 21 2017
SANUWAVE Health Achieves High End of Revenue Guidance for Q4 2016 Jan 26 2017
SANUWAVE Health Provides Fourth Quarter Business Update Dec 20 2016
SANUWAVE Announces Cooperation with Ortho-Medico in Europe on a New 100 Subject Trial Treating... Dec 15 2016
SNWV: Guiding For FDA Response in January Nov 16 2016
SANUWAVE Health, Inc. :SNWV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016 Nov 10 2016
SANUWAVE Health to Hold Third Quarter 2016 Financial Results and Business Update Call on Wednesday,... Nov 02 2016
SANUWAVE Announces Exhibition at MEDICA in Cooperation with Ortho-Medico in Europe - Visit Us at... Oct 21 2016
SNWV: De Novo Regulatory Pathway Makes Sense Aug 22 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)